login

Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV

AIDSPublished 1 February 1998
R. J. Simonds, Richard W. Steketee, Steven Nesheim, Pamela B. Matheson, Paul Palumbo, Lindsay S. Alger
Citations132
SJR quartileQ1
SJR score1.21
SNIP0.90

TL;DR

Perinatal HIV transmission risk has declined with increasing perinatal zidovudine use and changes in other factors, and further reduction in transmission may be possible by reducing the incidence of other potentially modifiable risk factors, such as long duration of membrane rupture and prematurity.

Abstract

Perinatal HIV transmission risk has declined with increasing perinatal zidovudine use and changes in other factors. Further reduction in transmission for women taking zidovudine may be possible by reducing the incidence of other potentially modifiable risk factors, such as long duration of membrane rupture and prematurity.

Keywords

Immunology and MicrobiologyMedicine